Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis. GAIMS J MED SCI. 2022;2(1 (Jan-Jun):30-35. Accessed October 25, 2025. http://gjms.gaims.ac.in/ojs/index.php/gjms/article/view/43